Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 22;13(Suppl 1):S65-S70.
doi: 10.1093/inthealth/ihaa084.

Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis

Patrick J Lammie  1 , Katherine M Gass  2 , Jonathan King  3 , Michael S Deming  1 , David G Addiss  1 , Gautam Biswas  3 , Eric A Ottesen  2 , Ralph Henderson  2
Affiliations
Review

Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis

Patrick J Lammie et al. Int Health. .

Erratum in

Abstract

The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was established with the ambitious goal of eliminating LF as a public health problem. The remarkable success of the GPELF over the past 2 decades in carrying out its principal strategy of scaling up and scaling down mass drug administration has relied first on the development of a rigorous monitoring and evaluation (M&E) framework and then the willingness of the World Health Organization and its community of partners to modify this framework in response to the practical experiences of national programmes. This flexibility was facilitated by the strong partnership that developed among researchers, LF programme managers and donors willing to support the necessary research agenda. This brief review summarizes the historical evolution of the GPELF M&E strategies and highlights current research needed to achieve the elimination goal.

Keywords: disease elimination; lymphatic filariasis; mass drug administration; monitoring and evaluation.

PubMed Disclaimer

References

    1. Ottesen EA, Duke BO, Karam M et al. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Org. 1997;75(6):491–503. - PMC - PubMed
    1. Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997;13(10):401–4. - PubMed
    1. World Health Organization Department of Control of Neglected Tropical Diseases . Generic framework for control, elimination and eradication of neglected tropical diseases. Available from: http://apps.who.int/iris/bitstream/10665/205080/1/WHO_HTM_NTD_2016.6_eng... [accessed 29 September 2020].
    1. Ichimori K, King J, Engels D et al. Global programme to eliminate lymphatic filariasis: the processes underlying programme success. PLoS Negl Trop Dis. 2014;8(12):e3328. - PMC - PubMed
    1. World Health Organization Lymphatic Filariasis Elimination Programme . Report of a WHO informal consultation on epidemiologic approaches to lymphatic filariasis elimination: initial assessment, monitoring, and certification. WHO/FIL/99.195. Available from: https://apps.who.int/iris/handle/10665/66440 [accessed 29 September 2020].

Publication types

MeSH terms